• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC SWITZERLAND GMBH CENTRIMAG 2ND GENERATION PRIMARY CONSOLE; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC SWITZERLAND GMBH CENTRIMAG 2ND GENERATION PRIMARY CONSOLE; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 201-90411
Device Problem Decreased Pump Speed (1500)
Patient Problem Hemolysis (1886)
Event Date 06/14/2021
Event Type  Injury  
Manufacturer Narrative
The patient's gender was not provided.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient was initiated with centrimag veno-venous (vv) extracorporeal membrane oxygenation (ecmo) on (b)(6) 2021.It was set to 5450 rpm/7.03 lpm.The system never reached 5500 rpm and would not reach 5450 by 19:00 on (b)(6) 2021.At 5400 rpm and 6.95 lpm flow the patient had a circuit change for hemolysis on (b)(6) 2021.The patient was still on the current centrimag and never achieved 5500 rpms.The console and motor were placed on (b)(6) primed circuit and tested to see if 5500 rpms could be achieved.The circuit ran at 5500 rpms for greater than 2 hours.The circuit was placed on a demo training loop at approximately 14:00 and the rpms were at 5500 with flow at approximately at 6.74 lpms.When clamped/unclamped on the drainage side, rpms would fluctuate above/below 50-100 rpms but quickly returned to the 5500 rpm setting.It was unable to reproduce the sustained lower rpm reported issue.The circuit would continue to run on a training loop with added resistance to attempt to simulate the previous patient's settings for greater than 24 hours.It was felt that 5500 rpms were unable to be achieved related to the patient factors.Plan was to perform demo loop run and follow up with staff.Related manufacturer report number of motor: 3002893813-2021-00001.Related manufacturer report number of pump: 3002953813-2021-00004.
 
Manufacturer Narrative
Section d4: correction.Expiration date not applicable.Manufacturer's investigation conclusion: the reported event of not being able to reach 5500 rpm was not confirmed.The centrimag console (serial#: (b)(6) was returned for analysis and a log file was for review.A review of the downloaded log file showed events spanning approximately 4 days (on (b)(6) 2021 per time stamp).Events occurring on 10aug2021 took place during lab testing at abbott.Throughout the log file, the motor speed was adjusted several times.When the motor speed was adjusted to 5500 rpm, the motor was able to operate at a speed of, around, or slightly above 5500 rpm.There were no other notable alarms active in the log file.The centrimag motor was returned for and the reported event was unable to be confirmed via testing.The console was connected with the returned and associated equipment as well as to test equipment.The console was run for several days at 5500 rpm with no observed issues.The console was able to maintain a speed at 5500 rpm.The console was functionally tested and passed all tests.The root cause for the reported event was unable to be conclusively determined through this analysis.The device history records were reviewed for the centrimag 2nd generation primary console (serial#: (b)(6) and the console was found to pass all manufacturing and quality assurance specifications.The 2nd generation centrimag system operating manual section 4 entitled "warnings & precautions" warns "one additional 2nd generation centrimag primary console, motor and flow probe are required as backup system in the immediate vicinity of each patient whenever the centrimag or pedivas blood pump is used.The backup console must be connected to the backup motor and to the backup flow probe, have a battery charge sufficient for at least one hour of operation, be connected to ac power (except during transport) and be immediately available should the main console, motor or flow probe experience a malfunction." the 2nd generation centrimag system operating manual section 10 entitled "emergency and troubleshooting" states that "the recommended practice whenever there is a 2nd generation centrimag primary console or motor malfunction is to replace the console and motor as a set.Remove the blood pump from the malfunctioning motor and console and place the blood pump in the backup motor and console to continue patient support.Do not exchange individual motors or individual consoles during patient support." the 2nd generation centrimag system operating manual section 12.1 entitled "appendix i ¿ primary console alarms and alerts" contains a list of console alarms and alerts, as well as appropriate operator response to these events.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRIMAG 2ND GENERATION PRIMARY CONSOLE
Type of Device
CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
THORATEC SWITZERLAND GMBH
technoparkstrasse 1
zurich CH-80 05
SZ  CH-8005
MDR Report Key12283139
MDR Text Key280523382
Report Number3002953813-2021-00003
Device Sequence Number1
Product Code DWA
Combination Product (y/n)N
PMA/PMN Number
K131179
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/05/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2022
Device Model Number201-90411
Device Lot Number7530545
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2021
Was the Report Sent to FDA? No
Date Manufacturer Received09/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age41 YR
Patient Weight137
-
-